EUVIMEDEUVIMED entdecken
Crossref

Abnormal left ventricular mass as a prognostic marker for outcomes in infants and children with cirrhosis

Dalia A Bashir, Sameer Thadani, Taylor Nack, Nour Gebara, Noelle Gorgis, Manpreet Virk, Anna M Banc Husu, Tam T Doan, Nhu Thao Nguyen Galvan, Muhammad Umair M Mian, Kathleen Hosek, Kelby Fuller und 8 weitere

Journal of Hepatology · 2026-10

DOI: 10.1016/j.jhep.2026.09.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatology, 2026-10. Verfasst von Dalia A Bashir und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Critical Care Medicine-Liver ICU, Department of Pediatrics, Texas Children's Hospital/Baylor College of Medicine. Die Arbeit nennt 43 Literaturangaben. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIMS: Cirrhotic cardiomyopathy (CCM), a clinically consequential comorbidity of cirrhosis, remains undefined and underappreciated in children. This study aimed to characterize myocardial structural, functional, morphometric, and histopathologic features in pediatric cirrhosis and objectively derive a reliable echocardiographic (2DE) metric to predict perioperative adverse events, including mortality. METHODS: 2DE, morphometry, histopathology, and vasoactive-inotropic score (VIS) were compared between children with (n=226) and without (n=160) cirrhosis listed for liver transplantation (LT) over 2011-2021. Discriminatory performance of left ventricular mass index (height)2.7(LVMI g/m2.7) for predicting waitlist decompensation, composite serious adverse events post liver transplant and mortality was assessed using ROC analysis, with AUCs and optimal thresholds compared against PELD-Cr/MELD scores. RESULTS: LV mass was significantly higher in children with cirrhosis on 2DE and necropsy specimens compared to non-cirrhotic controls, with ∼25% demonstrating LV hypertrophy, with OR of 6.9 [CI 3,16], p< 0.0001. In the cirrhotic cohort, LVMI correlated with vasoactive needs under stress of LT (p

Schlagwörter

Stichwörter der Autor:innen

echocardiographyliver-heart interactionmyocardial fibrosis

Autor:innen und Institutionen

  • Division of Critical Care Medicine-Liver ICU, Department of Pediatrics, Texas Children's Hospital/Baylor College of Medicine.
  • Divisions of Critical Care and Division of Nephrology, Texas Children's Hospital, Baylor College of Medicine.
  • Department of Surgery, Baylor College of Medicine.
  • Division of Critical Care Medicine, Department of Pediatrics, Texas Children's Hospital/Baylor College of Medicine.
  • Division of Critical Care Medicine, Children's Hospital of Philadelphia, University of Pennsylvania.
  • Division of Gastroenterology and Hepatology- Department of Pediatrics, Texas Children's Hospital/Baylor College of Medicine.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Bashir, D. A., Thadani, S., Nack, T., Gebara, N., Gorgis, N., Virk, M., Banc Husu, A. M., Doan, T. T., Nguyen Galvan, N. T., Umair M Mian, M., Hosek, K., Fuller, K., Patel, K. R., Sabapathy, D., James, S. T., Fogarty, T., Penny, D. J., Dinh, D., Kennedy, C. E., & Desai, M. S. (2026). Abnormal left ventricular mass as a prognostic marker for outcomes in infants and children with cirrhosis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2026.09.024

Vancouver

Bashir DA, Thadani S, Nack T, Gebara N, Gorgis N, Virk M, et al. Abnormal left ventricular mass as a prognostic marker for outcomes in infants and children with cirrhosis. Journal of Hepatology. 2026. doi:10.1016/j.jhep.2026.09.024

BibTeX
@article{Bashir2026,
  author = {Bashir, Dalia A and Thadani, Sameer and Nack, Taylor and Gebara, Nour and Gorgis, Noelle and Virk, Manpreet and Banc Husu, Anna M and Doan, Tam T and Nguyen Galvan, Nhu Thao and Umair M Mian, Muhammad and Hosek, Kathleen and Fuller, Kelby and Patel, Kalyani R and Sabapathy, Divya and James, Sammie T and Fogarty, Thomas and Penny, Daniel J and Dinh, Duy and Kennedy, Curtis E and Desai, Moreshwar S},
  title = {Abnormal left ventricular mass as a prognostic marker for outcomes in infants and children with cirrhosis},
  journal = {Journal of Hepatology},
  year = {2026},
  doi = {10.1016/j.jhep.2026.09.024}
}
Kostenlos starten →